The Relation of Serum Potassium Concentration with Cardiovascular Events and Mortality in Community-Living Individuals
- 31 January 2017
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 12 (2), 245-252
- https://doi.org/10.2215/cjn.06290616
Abstract
Hyperkalemia is associated with adverse outcomes in patients with CKD and in hospitalized patients with acute medical conditions. Little is known regarding hyperkalemia, cardiovascular disease (CVD), and mortality in community-living populations. In a pooled analysis of two large observational cohorts, we investigated associations between serum potassium concentrations and CVD events and mortality, and whether potassium-altering medications and eGFR<60 ml/min per 1.73 m2 modified these associations. Among 9651 individuals from the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS), who were free of CVD at baseline (2000-2002 in the MESA and 1989-1993 in the CHS), we investigated associations between serum potassium categories (<3.5, 3.5-3.9, 4.0-4.4, 4.5-4.9, and ≥5.0 mEq/L) and CVD events, mortality, and mortality subtypes (CVD versus non-CVD) using Cox proportional hazards models, adjusting for demographics, time-varying eGFR, traditional CVD risk factors, and use of potassium-altering medications. Compared with serum potassium concentrations between 4.0 and 4.4 mEq/L, those with concentrations ≥5.0 mEq/L were at higher risk for all-cause mortality (hazard ratio, 1.41; 95% confidence interval, 1.12 to 1.76), CVD death (hazard ratio, 1.50; 95% confidence interval, 1.00 to 2.26), and non-CVD death (hazard ratio, 1.40; 95% confidence interval, 1.07 to 1.83) in fully adjusted models. Associations of serum potassium with these end points differed among diuretic users (Pinteraction<0.02 for all), such that participants who had serum potassium ≥5.0 mEq/L and were concurrently using diuretics were at higher risk of each end point compared with those not using diuretics. Serum potassium concentration ≥5.0 mEq/L was associated with all-cause mortality, CVD death, and non-CVD death in community-living individuals; associations were stronger in diuretic users. Whether maintenance of potassium within the normal range may improve clinical outcomes requires future study.This publication has 27 references indexed in Scilit:
- Magnesium and the Risk of Cardiovascular Events: A Meta-Analysis of Prospective Cohort StudiesPLOS ONE, 2013
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CThe New England Journal of Medicine, 2012
- Severe hyperkalemia requiring hospitalization: predictors of mortalityCritical Care, 2012
- The Relationship of Left Ventricular Mass and Geometry to Incident Cardiovascular Events: The MESA (Multi-Ethnic Study of Atherosclerosis) StudyJournal of the American College of Cardiology, 2008
- Electrocardiographic manifestations of hyperkalemiaThe American Journal of Emergency Medicine, 2000
- Assessing the use of medications in the elderly: Methods and initial experience in the cardiovascular health studyJournal of Clinical Epidemiology, 1992
- The cardiovascular health study: Design and rationaleAnnals of Epidemiology, 1991
- No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1990
- Hyperkalemia‐induced bundle branch block and complete heart blockClinical Cardiology, 1981
- Hyperkalemia, cardiac conduction, and the electrocardiogram: A reviewAmerican Heart Journal, 1974